Prognostic biomarkers in oral squamous cell carcinoma: a systematic review

C Rivera, AK Oliveira, RAP Costa, T De Rossi… - Oral oncology, 2017 - Elsevier
Over the years, several tumor biomarkers have been suggested to foresee the prognosis
oral squamous cell carcinoma (OSCC) patients. Here, we present a systematic review to …

Targeting of IL-4 and IL-13 receptors for cancer therapy

A Suzuki, P Leland, BH Joshi, RK Puri - Cytokine, 2015 - Elsevier
The Th2 cytokines, interleukin (IL)-4 and-13, are structurally and functionally related. They
regulate immune responses and the immune microenvironment, not only under normal …

Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: A review of the literature

S Blatt, M Krüger, T Ziebart, K Sagheb… - Journal of Cranio …, 2017 - Elsevier
Oral squamous cell carcinoma (OSCC) represents the sixth most common cancer,
accounting for 2–4% of all malignancies worldwide. The overall survival rate of less than …

[HTML][HTML] Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge

MNMR Petruzzi, K Cherubini, FG Salum… - Diagnostic …, 2017 - Springer
Background Oral squamous cell carcinoma (OSCC) accounts over 90% of malignant
neoplasms of the oral cavity. This pathological entity is associated to a high mortality rate …

[HTML][HTML] Inflammatory cytokines mediating the effect of oral lichen planus on oral cavity cancer risk: a univariable and multivariable mendelian randomization study

T Zheng, C Liu, Y Wang, H Zhou, R Zhou, X Zhu, Z Zhu… - BMC Oral Health, 2024 - Springer
Background While observational studies and experimental data suggest a link between oral
lichen planus (OLP) and oral cavity cancer (OCC), the causal relationship and the role of …

[HTML][HTML] Group 2 innate lymphoid cells: a double-edged sword in cancer?

E Maggi, I Veneziani, L Moretta, L Cosmi, F Annunziato - Cancers, 2020 - mdpi.com
Simple Summary Group 2 innate lymphoid cells (ILC2s), like other ILCs, are a new resident
cell subset of innate immunity that provides the first line of defense against pathogens such …

Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cells

L Chi, MH Na, HK Jung, SMP Vadevoo, CW Kim… - Journal of Controlled …, 2015 - Elsevier
A growing body of evidence suggests that pathological lesions express tissue-specific
molecular targets or biomarkers within the tissue. Interleukin-4 receptor (IL-4R) is …

Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth

P Guruprasath, J Kim, GR Gunassekaran, L Chi, S Kim… - Biomaterials, 2017 - Elsevier
Abstract IL-4 receptor (IL-4R) is commonly up-regulated on tumor cells, and interactions
between the receptor and Interleukin-4 (IL-4) can induce the expression of anti-apoptotic …

[HTML][HTML] The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small …

D Pastuszak-Lewandoska… - Molecular Diagnosis & …, 2018 - Springer
Abstract Background The interleukin (IL)-4/IL-13/signal transducer and activator of
transcription (STAT) 6 signaling pathway and the SOCS3 gene, one of its main regulators …

[HTML][HTML] IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice

M Xie, X Wu, J Zhang, C He - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract IL-13 receptor subunit alpha-2 (IL13Rα2) is associated with poor prognosis in some
cancers. However, the role of IL13Rα2 in lung cancer remains unknown. We showed that …